Bank Of New York Mellon Corp Cytek Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$8.44 - $13.47 $3.3 Million - $5.26 Million	390,541 New	390,541 $3.59 Billion
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $3.86 Million - $6.3 Million	397,036 New	397,036 $4.05 Million
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $723,853 - $1.02 Million	66,045 Added 20.14%	394,034 $5.8 Million
Q2 2022 Aug 15, 2022	BUY	$7.41 - $11.56 $456,856 - $712,720	61,654 Added 23.15%	327,989 $3.52 Million
Q1 2022 May 11, 2022	BUY	$9.89 - $17.25 $2.11 Million - $3.68 Million	213,476 Added 403.86%	266,335 $2.87 Million
Q4 2021 Feb 11, 2022	BUY	$16.14 - $25.04 $230,640 - $357,821	14,290 Added 37.05%	52,859 $863,000
Q3 2021 Nov 12, 2021	BUY	$17.52 - $27.93 $675,728 - $1.08 Million	38,569 New	38,569 $826,000

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $874M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.